Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1998-6-4
pubmed:abstractText
The recently identified PTEN/MMAC1 gene is a candidate tumor suppressor implicated in multiple tumor types based on mutations or homozygous deletions of the gene in certain human cancers. No studies of PTEN/MMAC1 mRNA or protein expression in cancer cells have been reported, primarily because of significant numbers of normal cells contaminating most tumor samples and because of the lack of antibody reagents. We examined PTEN/MMAC1 in advanced prostate cancer for gene mutations or abnormalities in expression by using a series of recently derived xenografts free of normal human cells and a PTEN/MMAC1-specific antibody. Only 1 of 10 tumors contained a homozygous deletion of PTEN/MMAC1, and no mutations were detected in the entire coding region of the remaining nine xenografts. However, five of these showed reduced or absent PTEN/MMAC1 expression by Northern analysis and reverse transcription-PCR of mRNA. PTEN/MMAC1 mRNA expression was restored in nonexpressing prostate cancer cells by in vitro treatment with the demethylating agent 5-azadeoxycytidine. Alterations in PTEN/MMAC1 expression were confirmed at the protein level by immunoblot analysis, and immunohistochemical studies show that the endogenous wild-type PTEN/MMAC1 protein is localized exclusively in the cytoplasm. These results demonstrate that loss of PTEN/MMAC1 expression occurs frequently in advanced prostate cancer.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-7550353, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-7553621, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-7553622, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-7585152, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-7585546, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-7624798, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-7937876, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-8023167, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-8533086, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-8996584, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9018245, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9072974, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9090379, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9095173, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9140396, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9171999, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9187108, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9256433, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9288767, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9307275, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9326929, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9371490, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9443392, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9556415, http://linkedlifedata.com/resource/pubmed/commentcorrection/9560261-9816265
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
28
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5246-50
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:9560261-Azacitidine, pubmed-meshheading:9560261-Cell Compartmentation, pubmed-meshheading:9560261-Cytoplasm, pubmed-meshheading:9560261-DNA Methylation, pubmed-meshheading:9560261-Gene Expression Regulation, Neoplastic, pubmed-meshheading:9560261-Genes, Tumor Suppressor, pubmed-meshheading:9560261-Humans, pubmed-meshheading:9560261-Male, pubmed-meshheading:9560261-Mutation, pubmed-meshheading:9560261-Neoplasm Transplantation, pubmed-meshheading:9560261-PTEN Phosphohydrolase, pubmed-meshheading:9560261-Phosphoric Monoester Hydrolases, pubmed-meshheading:9560261-Prostate-Specific Antigen, pubmed-meshheading:9560261-Prostatic Neoplasms, pubmed-meshheading:9560261-Protein Tyrosine Phosphatases, pubmed-meshheading:9560261-RNA, Messenger, pubmed-meshheading:9560261-RNA, Neoplasm, pubmed-meshheading:9560261-Sequence Deletion, pubmed-meshheading:9560261-Transplantation, Heterologous, pubmed-meshheading:9560261-Tumor Suppressor Proteins
pubmed:year
1998
pubmed:articleTitle
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression.
pubmed:affiliation
Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't